-
Sea of colour as Malaysia's Hindus mark Thaipusam with piercings and prayer
-
Exiled Tibetans choose leaders for lost homeland
-
Afghan returnees in Bamiyan struggle despite new homes
-
Mired in economic trouble, Bangladesh pins hopes on election boost
-
Chinese cash in jewellery at automated gold recyclers as prices soar
-
Israel to partially reopen Gaza's Rafah crossing
-
'Quiet assassin' Rybakina targets world number one after Melbourne win
-
Deportation raids drive Minneapolis immigrant family into hiding
-
Nvidia boss insists 'huge' investment in OpenAI on track
-
'Immortal' Indian comics keep up with changing times
-
With Trump mum, last US-Russia nuclear pact set to end
-
In Sudan's old port of Suakin, dreams of a tourism revival
-
Narco violence dominates as Costa Rica votes for president
-
Snowstorm barrels into southern US as blast of icy weather widens
-
LA Olympic chief 'deeply regrets' flirty Maxwell emails in Epstein files
-
Rose powers to commanding six-shot lead at Torrey Pines
-
Barca wasteful but beat Elche to extend Liga lead
-
Konate cut short compassionate leave to ease Liverpool injury crisis
-
Separatist attacks in Pakistan kill 33, dozens of militants dead
-
Dodgers manager Roberts says Ohtani won't pitch in Classic
-
Arsenal stretch Premier League lead as Chelsea, Liverpool stage comebacks
-
Korda defies cold and wind to lead LPGA opener
-
New head of US mission in Venezuela arrives as ties warm
-
Barca triumph at Elche to extend Liga lead
-
Ekitike, Wirtz give Liverpool sight of bright future in Newcastle win
-
West Indies 'tick boxes' in shortened T20 against South Africa
-
Chelsea have something 'special' says Rosenior
-
De Zerbi 'ready to go to war' to solve Marseille troubles
-
Hornets hold off Wemby's Spurs for sixth NBA win in a row
-
Moyes blasts killjoy booking after Everton's late leveller
-
Ex-prince Andrew again caught up in Epstein scandal
-
Bayern held at Hamburg to open door for Dortmund
-
Atletico stumble to draw at Levante, Villarreal held
-
Chelsea stage impressive fightback to beat West Ham
-
Arsenal stretch Premier League lead, Chelsea fightback breaks Hammers' hearts
-
Napoli edge Fiorentina as injury crisis deepens
-
How Lego got swept up in US-Mexico trade frictions
-
UK rights campaigner Tatchell arrested at pro-Palestinian protest
-
Iran says progress made towards US talks despite attack jitters
-
'Empowering': Ireland's first female sumo wrestler blazes a trail
-
US judge denies Minnesota bid to suspend immigration sweeps
-
Ukraine hit by mass power outages after 'technical malfunction'
-
AC Milan prolong France 'keeper Maignan deal by five years
-
Arteta hails Arsenal's statement rout of Leeds
-
Marseille buckle as Paris FC battle back for draw
-
Protesters demand 'justice' one month after Swiss bar fire
-
Philadelphia's Paul George gets 25-game NBA drugs ban
-
La Rochelle suffer defeat after shock Atonio retirement
-
'It wasn't working': Canada province ends drug decriminalization
-
Kishan, Arshdeep star as India down New Zealand in T20 finale
Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
B.Torres--AT